Alzheimer disease

Dis Mon. 2010 Sep;56(9):484-546. doi: 10.1016/j.disamonth.2010.06.001.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / therapy*
  • Amyloid beta-Peptides / metabolism
  • Aniline Compounds
  • Antioxidants / therapeutic use
  • Biomarkers / metabolism
  • Brain / pathology
  • Cerebral Amyloid Angiopathy / diagnosis
  • Cholinergic Agents / therapeutic use
  • Dementia / diagnosis
  • Diagnosis, Differential
  • Diet, Mediterranean
  • Estrogen Replacement Therapy
  • Global Health
  • Humans
  • Immunotherapy / methods
  • Incidence
  • Mutation / genetics
  • Nerve Growth Factors / therapeutic use
  • Neurofibrillary Tangles
  • Plaque, Amyloid
  • Positron-Emission Tomography
  • Prevalence
  • Risk Factors
  • Thiazoles
  • Treatment Outcome
  • tau Proteins / metabolism

Substances

  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • Amyloid beta-Peptides
  • Aniline Compounds
  • Antioxidants
  • Biomarkers
  • Cholinergic Agents
  • Nerve Growth Factors
  • Thiazoles
  • tau Proteins